Clinical Research Trials

FGCL-4592

" FGCL-4592-060, A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis . "

" The purpose of this study is to find out if the experimental drug roxadustat (also known as FG-4592) is safe and effective for treating anemia in people with chronic kidney disease who are not on dialysis. "

Principal Investigator: "Dr. Gary Shaw, MD"

Contact: Study Coordinator

Phone (Main): (231) 487-3157

IRB Number: 2015-02-001

Current Trial Type: 2174627